Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy.
Saved in:
| Title: | Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy. |
|---|---|
| Authors: | Harris AR; Department of Obstetrics and Gynecology, Gynecologic Oncology Division, University of Virginia, Charlottesville, VA, United States.; Department of Pathology, University of Virginia, Charlottesville, VA, United States., Esparza S; Department of Biomedical Engineering & Mechanics, Fralin Biomedical Research Institute, Virginia Polytechnic Institute and State University, Roanoke, VA, United States., Azimi MS; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States., Cornelison R; Department of Obstetrics and Gynecology, Gynecologic Oncology Division, University of Virginia, Charlottesville, VA, United States.; Department of Pathology, University of Virginia, Charlottesville, VA, United States., Azar FN; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States., Llaneza DC; Department of Obstetrics and Gynecology, Gynecologic Oncology Division, University of Virginia, Charlottesville, VA, United States., Belanger M; Department of Chemistry, University of Virginia, Charlottesville, VA, United States., Mathew A; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States., Tkachenko S; Department of Genetics & Genome Sciences, Lerner Research Institute, Cleveland, OH, United States., Perez MJ; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States., Rosean CB; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States., Bostic RR; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States., Cornelison RC; Department of Biomedical Engineering & Mechanics, Fralin Biomedical Research Institute, Virginia Polytechnic Institute and State University, Roanoke, VA, United States., Tate KM; Department of Biomedical Engineering & Mechanics, Fralin Biomedical Research Institute, Virginia Polytechnic Institute and State University, Roanoke, VA, United States., Peirce-Cottler SM; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States., Paquette C; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.; Department of Pathology and Laboratory Medicine, Women & Infants Hospital of Rhode Island, Providence, RI, United States., Mills A; Department of Pathology, University of Virginia, Charlottesville, VA, United States., Landen CN; Department of Obstetrics and Gynecology, Gynecologic Oncology Division, University of Virginia, Charlottesville, VA, United States., Saucerman J; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States., Dillon PM; Department of Hematology and Oncology, University of Virginia, Charlottesville, VA, United States., Pompano RR; Department of Chemistry, University of Virginia, Charlottesville, VA, United States., Rutkowski MA; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, United States., Munson JM; Department of Biomedical Engineering & Mechanics, Fralin Biomedical Research Institute, Virginia Polytechnic Institute and State University, Roanoke, VA, United States.; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Mar 17; Vol. 12, pp. 801764. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.801764 |
